We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LXFR:NYSELuxfer Holdings PLC Analysis

Data as of 2026-06-17 - not real-time

$18.19

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Luxfer Holdings (LXFR) is trading at $18.19, comfortably above its 20‑day SMA of $17.11 and the 50‑day SMA of $15.29, confirming a bullish price structure. However, the 14‑day RSI sits at 72.7, indicating the stock is in overbought territory and could face short‑term pressure. The MACD line is marginally below its signal line, generating a bearish signal despite the overall uptrend. Fundamentals reveal a steep revenue decline of 13.5% YoY and a modest gross margin of 24%, suggesting earnings are being squeezed. Adjusted EBITDA margin improved to 14.7% and adjusted EPS rose 17% year‑over‑year, showing that cost discipline and pricing power are beginning to offset volume weakness. The current PE of 43.3 far exceeds the industry average of 31.2, while the DCF‑derived fair value of $9.57 is less than half the market price, flagging the stock as overvalued.
The dividend yield of 2.86% is attractive but the payout ratio of 124% raises concerns about sustainability. A beta of 1.31 and a 30‑day volatility of nearly 30% point to heightened market sensitivity, compounded by a decreasing volume trend that could impair liquidity. Forward PE of 12.9 and projected EPS of $1.42 suggest earnings are expected to accelerate, providing a growth catalyst for medium‑term investors. With operations spanning North America, Europe and Asia Pacific, geographic diversification mitigates country‑specific risk, though exposure to defense and aerospace regulations remains medium. In this mixed technical‑fundamental environment, the stock appears poised for a short‑term pullback, a medium‑term upside, and a cautious long‑term stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • overbought RSI
  • bearish MACD signal
  • proximity to support level

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • forward PE compression
  • improving EBITDA margin
  • bullish SMA alignment

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • high valuation versus DCF
  • revenue decline
  • unsustainable dividend payout

Key Metrics & Analysis

Financial Health

Revenue Growth-13.50%
Profit Margin1.56%
P/E Ratio43.3
ROE5.06%
ROA5.85%
Debt/Equity30.78
P/B Ratio2.1
Op. Cash Flow$24.5M
Free Cash Flow$23.7M
Industry P/E31.2

Technical Analysis

TrendBullish
RSI72.7
Support$15.00
Resistance$18.74
MA 20$17.11
MA 50$15.29
MA 200$13.93
MACDBearish
VolumeDecreasing
Fear & Greed Index92.2

Valuation

Fair Value$9.57
Target Price$20.50
Upside/Downside12.70%
GradeOvervalued
TypeBlend
Dividend Yield2.86%

Risk Assessment

Beta1.31
Volatility29.96%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.